Raman spectroscopy is used to identify the biochemical differences between normal brain tissue (cerebellum and meninges) compared with tumor (glioblastoma, medulloblastoma, schwannoma and meningioma) through biochemical information obtained from the sample.

A total of 263 spectra were obtained from fragments of cerebellum normal (65), meninges normal (69), glioblastoma (28), schwannoma (8), medulloblastoma (19), and meningioma (74), which is collected using dispersive the Raman spectrometer ( 830 nm, near infrared power, output 350 mW, 20 s exposure time to obtain the spectrum), coupled to the Raman probe.

A model spectral based quadratic fit was developed to estimate the concentration of biochemistry of 16 biochemical compounds present in brain tissue, among them the most characterized the spectrum of brain tissue, such as linolenic acid, triolein, cholesterol, sphingomyelin, phosphatidylcholine, β-carotene, collagen, phenylalanine, DNA, glucose, and blood.

Of biochemical information, classification spectra in normal and tumor groups was performed according to the type of brain tumor and corresponding normal tissue. The classifications used in the model of discrimination is (a) the concentration of the biochemical constituents of the brain, through a linear discriminant analysis (LDA), and (b) the spectrum of the network, through discrimination by partial least squares (PLS-DA) regression.

The model obtained 93.3% accuracy with LDA discrimination between normal and tumor cerebellum groups separated according to the concentration of biochemical constituents and 94.1% in discrimination by PLS-DA using the whole spectrum. The results obtained showed that the Raman technique is a promising tool for distinguishing concentrations of biochemical compounds present in brain tissue, both normal and tumor. The concentration predicted by models of biochemical and all information contained in Raman spectra were both able to classify pathologic group.

Persistence biochemistry of prostate specific antigen after robot-assisted Laparoscopic Radical Prostatectomy: Tumor localization using PSMA PET / CT imaging

Since the introduction of radiolabeled prostate-specific membrane antigen (PSMA) positron emission tomography / computed tomography (PET / CT), the ability to visualize recurrent prostate cancer has increased substantially. However, PSMA radiolabeled diagnostic accuracy of PET / CT in patients with biochemical persistence (BCP; ie, continuously measured prostate-specific antigen (PSA) -values ​​after robot-assisted laparoscopic radical prostatectomy (RARP)) largely lacking.

Therefore, the aim of this study was to determine the role of PSMA (ie, 18F-DCFPyL or 68Ga-PSMA-11) PET / CT imaging in patients with BCP after RARP and to evaluate the site of disease are persistent on PSMA PET / CT. Methods: A total of 150 consecutive patients with BCP after undergoing RARP PSMA radiolabeled PET / CT imaging were retrospectively evaluated. BCP is defined as any first detectable serum PSA values ​​after RARP (≥0.1 ng / mL) for at least 6 weeks after surgery, the absence of an undetectable PSA values ​​after RARP.

A multivariable logistic regression analysis was performed to identify predictors for the detection of metastases outside the prostate fossa (≥miN1) on PSMA PET / CT. Results: A PSMA PET / CT was performed in the PSA-median value of 0.60 ng / mL (interquartile range (IQR) from 0.3 to 2.4) after a median period of 6 months (IQR 4-10) following RARP. In total, 101/150 patients (67%) had lesions with PSMA-expression PET / CT, which was 89/150 patients (59%) had lesions with increased expression of PSMA sites outside the prostatic fossa.

Fermentation optimization, purification and biochemical characterization of ι-carrageenase of marine bacteria Cellulophaga Baltica

Degrading marine bacterium ι-carrageenan, Cellulophaga Baltica, isolated from the surface of red algae filaments fucoides Vertebrates. ι-carrageenase maximum production is optimized by single factor experiment. The optimum fermentation conditions was 1.6 g / L furcellaran, 4 g / L of yeast extract as a carbon source, 5 g / L sea salt, and 48 hours of incubation at 20 ° C. Extracellular ι-carrageenase of culture supernatant purified by ultrafiltration , ammonium sulfate precipitation, and finally with anion exchange chromatography, showing 26 fold increase in specific activity compared to that in the crude enzyme.

According to the results of SDS-PAGE and HPLC-SEC, estimated molecular weight of 31 kDa purified enzyme. Purified enzyme showed maximum specific activity of 571 U / mg at 40 ° C and pH 7.5 to 8.0. It retains 73% of the total activity below 40 ° C and 90% of total activity at pH 7.2.

Especially, the enzyme is ι-carrageenase cold-adapted, which showed 33.4% of the maximum activity at 10 ° C. The enzyme is stimulated by Na +, K +, and NH4 +, while Ca 2+, Mg 2+, Fe 3+, sea salt and EDTA acts as an inhibitor of the enzyme.

Effect of Ramadan intermittent fasting on cognitive responses, physical and biochemical for heavy short-term exercise in young female elite handball players

This study aims to assess the effects of intermittent fasting Ramadan (RF) in response to cognitive, physical and biochemistry to exercise in young female elite handball players. Twelve athletes participated in three experimental sessions: one week before Ramadan (BR), in the first week of Ramadan (FWR) and during the last week of Ramadan (LWR).

Crossover studies carried out in Tunisia during the 2013 Ramadan which takes place from 9 July to 7 August. During each session, a battery test is performed as follows: Index Hooper, tests alertness (VT), Epworth sleepiness scale (ESS), five test jump (5-JT), modified agility T-test (MAT), the maximum stood ball speed test – throw (MSBVT) and Running-based Anaerobic Sprint (RAST) test. Ratings of perceived exertion (RPE) was recorded immediately after the RAST.

Blood samples were taken before and after exercise during each session. The results showed that the higher the ESS score for LWR of BR (p <0.05). In addition, MSBVT time decreased (p <0.05) for LWR, because it improved performance. Strength three final sprint of RAST decreased significantly only for LWR compared with BR (p <0.05). RAST fatigue index and higher RPE scores for LWR more than BR (p <0.05).

The results showed also measures hematology (blood cell, namely, red, hemoglobin, and hematocrit), plasma osmolarity and energetic markers are not affected by RF. Biomarkers higher muscle damage after RAST only for LWR compared with BR (p <0.01 for all). In conclusion, increased RF performance decline RAST ESS and associated with higher muscle damage and fatigue, especially on the LWR. This change can be attributed to the previous and circadian rhythm sleep disorders than malnutrition or dehydratation.

 

GZMB Antibody

CSB-PA272248-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against GZMB. Recognizes GZMB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100

GZMB Antibody

1-CSB-PA108047
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against GZMB. Recognizes GZMB from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

GZMB Antibody

ABD7012 100ug
EUR 325

GZMB Antibody

KAA346M03F03C-100ug 100 ug
EUR 320
Description: Monoclonal Antibody

GZMB Antibody

KAA346M03F03C-1mg 1 mg
EUR 1600
Description: Monoclonal Antibody

GZMB Antibody

KAA346M03F03C-50ug 50 ug
EUR 224
Description: Monoclonal Antibody

GZMB Antibody

MBS7136741-005mL 0.05mL
EUR 220

GZMB Antibody

MBS7136741-01mL 0.1mL
EUR 300

GZMB Antibody

MBS7136741-5x01mL 5x0.1mL
EUR 1350

GZMB Antibody

MBS7132128-01mL 0.1mL
EUR 270

GZMB Antibody

MBS7132128-5x01mL 5x0.1mL
EUR 1200

GZMB Antibody

MBS7123752-005mL 0.05mL
EUR 190

GZMB Antibody

MBS7123752-01mL 0.1mL
EUR 270

GZMB Antibody

MBS7123752-5x01mL 5x0.1mL
EUR 1205

GZMB Antibody

MBS7123753-005mL 0.05mL
EUR 190

GZMB Antibody

MBS7123753-01mL 0.1mL
EUR 270

GZMB Antibody

MBS7123753-5x01mL 5x0.1mL
EUR 1205

GZMB Antibody

MBS9413077-005mL 0.05mL
EUR 300

GZMB Antibody

MBS9413077-01mL 0.1mL
EUR 390

GZMB Antibody

MBS9413077-5x01mL 5x0.1mL
EUR 1610

GZMB Antibody

MBS8504223-01mg 0.1mg
EUR 325

GZMB Antibody

MBS8504223-01mLAF405L 0.1mL(AF405L)
EUR 565

GZMB Antibody

MBS8504223-01mLAF405S 0.1mL(AF405S)
EUR 565

GZMB Antibody

MBS8504223-01mLAF610 0.1mL(AF610)
EUR 565

GZMB Antibody

MBS8504223-01mLAF635 0.1mL(AF635)
EUR 565

GZMB Antibody

MBS2518949-006mL 0.06mL
EUR 190

GZMB Antibody

MBS2518949-012mL 0.12mL
EUR 265

GZMB Antibody

MBS2518949-02mL 0.2mL
EUR 415

GZMB Antibody

MBS2518949-5x02mL 5x0.2mL
EUR 1835

GZMB Antibody

MBS9607665-01mL 0.1mL
EUR 260

GZMB Antibody

MBS9607665-02mL 0.2mL
EUR 305

GZMB Antibody

MBS9607665-5x02mL 5x0.2mL
EUR 1220

anti- GZMB antibody

FNab03737 100µg
EUR 702
Description: Antibody raised against GZMB

GZMB Antibody (C-term)

MBS9209305-008mL 0.08mL
EUR 210

GZMB Antibody (C-term)

MBS9209305-04mL 0.4mL
EUR 430

GZMB Antibody (C-term)

MBS9209305-5x04mL 5x0.4mL
EUR 1910

GZMB Antibody (N-term)

MBS9212735-008mL 0.08mL
EUR 210

GZMB Antibody (N-term)

MBS9212735-04mL 0.4mL
EUR 430

GZMB Antibody (N-term)

MBS9212735-5x04mL 5x0.4mL
EUR 1910

Anti-Human GZMB Antibody

MBS1569301-01mg 0.1mg
EUR 405

Anti-Human GZMB Antibody

MBS1569301-5x01mg 5x0.1mg
EUR 1520

Anti-Human GZMB Antibody

MBS1568472-01mg 0.1mg
EUR 405

Anti-Human GZMB Antibody

MBS1568472-5x01mg 5x0.1mg
EUR 1520

GZMB / GZMH Antibody

20-abx329145
  • Ask for price
  • Ask for price
  • 100 ug
  • 50 ug

GZMB/GZMH Antibody

1-CSB-PA009072
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against GZMB/GZMH. Recognizes GZMB/GZMH from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/5000

GZMB / GZMH Antibody

abx329145-100l 100 µl
EUR 187.5

GZMB/GZMH Antibody

MBS7118337-005mg 0.05mg
EUR 150

GZMB/GZMH Antibody

MBS7118337-01mg 0.1mg
EUR 190

GZMB/GZMH Antibody

MBS7118337-5x01mg 5x0.1mg
EUR 845

Granzyme B (GZMB) Antibody

20-abx109837
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Granzyme B (GZMB) Antibody

20-abx112844
  • Ask for price
  • Ask for price
  • 150 ul
  • 50 ul

Granzyme B (GZMB) Antibody

20-abx100561
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Granzyme B (GZMB) Antibody

20-abx128920
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Granzyme B (GZMB) Antibody

abx139484-01mg 0.1 mg
EUR 493.2

Granzyme B (GZMB) Antibody

20-abx013099
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg
  • 5 ug

Granzyme B (GZMB) Antibody

20-abx001994
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Granzyme B (GZMB) Antibody

20-abx210520
  • Ask for price
  • Ask for price
  • 100 ul
  • 50 ul

Granzyme B (GZMB) Antibody

20-abx210840
  • Ask for price
  • Ask for price
  • 100 ul
  • 50 ul

Granzyme B (GZMB) Antibody

abx233737-100ug 100 ug
EUR 661.2

Granzyme B (GZMB) Antibody

20-abx225208
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 50 ul

Granzyme B (GZMB) Antibody

20-abx172667
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Granzyme B (GZMB) Antibody

20-abx172668
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

Granzyme B (GZMB) Antibody

20-abx176702
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

Granzyme B (GZMB) Antibody

20-abx176703
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

Granzyme B (GZMB) Antibody

abx332436-100ul 100 ul
EUR 510

GZMB Antibody / Granzyme B

F54859-0.08ML 0.08 ml
EUR 140.25
Description: Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response.

GZMB Antibody / Granzyme B

F54859-0.4ML 0.4 ml
EUR 322.15
Description: Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response.

Granzyme B (GZMB) Antibody

abx210520-100l 100 µl
EUR 350

Granzyme B (GZMB) Antibody

abx210520-50l 50 µl
EUR 250

Granzyme B (GZMB) Antibody

abx172667-1ml 1 ml
EUR 262.5

Granzyme B (GZMB) Antibody

abx210840-100l 100 µl
EUR 350

Granzyme B (GZMB) Antibody

abx210840-50l 50 µl
EUR 250

Granzyme B (GZMB) Antibody

abx128920-100l 100 µl
EUR 250

Granzyme B (GZMB) Antibody

abx128920-1ml 1 ml
EUR 675

Granzyme B (GZMB) Antibody

abx128920-200l 200 µl
EUR 312.5

Granzyme B (GZMB) Antibody

abx112844-100l 100 µl
EUR 612.5

Granzyme B (GZMB) Antibody

abx139484-100l 100 µl
EUR 337.5

Granzyme B (GZMB) Antibody

abx139484-500l 500 µl Ask for price

Granzyme B (GZMB) Antibody

abx233737-100g 100 µg
EUR 350

Granzyme B (GZMB) Antibody

abx402403-100g 100 µg
EUR 287.5

Granzyme B (GZMB) Antibody

abx013099-100g 100 µg
EUR 237.5

Granzyme B (GZMB) Antibody

abx013099-10g 10 µg
EUR 43.75

Granzyme B (GZMB) Antibody

abx013099-200g 200 µg
EUR 312.5

Granzyme B (GZMB) Antibody

abx001994-100l 100 µl
EUR 400

Granzyme B (GZMB) Antibody

abx001994-20l 20 µl
EUR 175

Granzyme B (GZMB) Antibody

abx001994-50l 50 µl
EUR 275

Granzyme B (GZMB) Antibody

abx100561-100l 100 µl
EUR 262.5

Granzyme B (GZMB) Antibody

abx100561-1ml 1 ml
EUR 687.5

Granzyme B (GZMB) Antibody

abx100561-200l 200 µl
EUR 325

Granzyme B (GZMB) Antibody

abx109837-100l 100 µl
EUR 162.5

GZMB Antibody, HRP conjugated

1-CSB-PA010082LB01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against GZMB. Recognizes GZMB from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

GZMB Antibody, FITC conjugated

1-CSB-PA010082LC01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against GZMB. Recognizes GZMB from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

OAAN00893-50UL - GZMB Antibody

OAAN00893-50UL 50ul
EUR 149

GZMB Antibody, Biotin conjugated

1-CSB-PA010082LD01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against GZMB. Recognizes GZMB from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

OAAN00893-100UL - GZMB Antibody

OAAN00893-100UL 100ul
EUR 249

OAAN00893-200UL - GZMB Antibody

OAAN00893-200UL 200ul
EUR 389

OAAJ01774-100UL - GZMB Antibody

OAAJ01774-100UL 100ul
EUR 319

OAAF01817-100UG - GZMB Antibody

OAAF01817-100UG 100ug
EUR 329

OAAJ07486-100UL - GZMB Antibody

OAAJ07486-100UL 100uL
EUR 319

OASA00733-100UG - GZMB Antibody

OASA00733-100UG 0.1mg
EUR 309

OASA02840-100UG - GZMB Antibody

OASA02840-100UG 0.1mg
EUR 309

OAEE00403-100UG - GZMB Antibody

OAEE00403-100UG 0.1mg
EUR 239

GZMB Monoclonal Antibody

E10-31969 100μg/100μl
EUR 225
Description: Available in various conjugation types.

GZMB Conjugated Antibody

C32711 100ul
EUR 476.4

GZMB Polyclonal Antibody

A55359
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 20 ul
  • 50 ul
  • 100 ul

GZMB Polyclonal Antibody

A71559 50 μl
EUR 408

GZMB Polyclonal Antibody

E-AB-60730-120uL 120uL
EUR 320
Description: Unconjugated

GZMB Polyclonal Antibody

E-AB-60730-200uL 200uL
EUR 530
Description: Unconjugated

GZMB Polyclonal Antibody

E-AB-60730-60uL 60uL
EUR 200
Description: Unconjugated

GZMB Polyclonal Antibody

E-AB-60730-each each Ask for price
Description: Unconjugated

GZMB Polyclonal Antibody

MBS9126731-002mL 0.02mL
EUR 200

GZMB Polyclonal Antibody

MBS9126731-005mL 0.05mL
EUR 255

GZMB Polyclonal Antibody

MBS9126731-01mL 0.1mL
EUR 345

GZMB Polyclonal Antibody

MBS9126731-02mL 0.2mL
EUR 545

GZMB Polyclonal Antibody

MBS9126731-5x02mL 5x0.2mL
EUR 2265

GZMB Polyclonal Antibody

MBS2521358-002mL 0.02mL
EUR 140

GZMB Polyclonal Antibody

MBS2521358-006mL 0.06mL
EUR 180

GZMB Polyclonal Antibody

MBS2521358-012mL 0.12mL
EUR 260

GZMB Polyclonal Antibody

MBS2521358-02mL 0.2mL
EUR 405

GZMB Polyclonal Antibody

MBS2525619-002mL 0.02mL
EUR 135

GZMB Polyclonal Antibody

MBS2525619-006mL 0.06mL
EUR 180

GZMB Polyclonal Antibody

MBS2525619-012mL 0.12mL
EUR 255

GZMB Polyclonal Antibody

MBS2525619-02mL 0.2mL
EUR 400

GZMB Polyclonal Antibody

MBS2525619-5x02mL 5x0.2mL
EUR 1715

GZMB Conjugated Antibody

MBS9443809-01mLAF350 0.1mL(AF350)
EUR 480

GZMB Conjugated Antibody

MBS9443809-01mLAF405 0.1mL(AF405)
EUR 480

GZMB Conjugated Antibody

MBS9443809-01mLAF488 0.1mL(AF488)
EUR 480

GZMB Conjugated Antibody

MBS9443809-01mLAF555 0.1mL(AF555)
EUR 480

GZMB Conjugated Antibody

MBS9443809-01mLBiotin 0.1mL(Biotin)
EUR 480

GZMB Polyclonal Antibody

RD82685A-120uL 120μL
EUR 360
Description: Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein encoded by this gene is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response.

GZMB Polyclonal Antibody

RD82685A-200uL 200μL
EUR 630
Description: Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein encoded by this gene is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response.

GZMB Polyclonal Antibody

RD82685A-60uL 60μL
EUR 204
Description: Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein encoded by this gene is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response.

Granzyme B (GZMB) Antibody (PE)

abx201109-100tests 100 tests
EUR 710.4

Granzyme B (GZMB) Antibody (HRP)

20-abx108314
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Granzyme B (GZMB) Antibody (HRP)

abx108314-100g 100 µg
EUR 362.5

Granzyme B (GZMB) Antibody (HRP)

abx108314-20g 20 µg
EUR 162.5

Granzyme B (GZMB) Antibody (HRP)

abx108314-50g 50 µg
EUR 250

Anti-Human GZMB Antibody (Fv02)

MBS1564216-01mg 0.1mg
EUR 405

Anti-Human GZMB Antibody (Fv02)

MBS1564216-5x01mg 5x0.1mg
EUR 1520

Granzyme B (GZMB) Antibody (FITC)

20-abx106894
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Granzyme B (GZMB) Antibody (FITC)

abx106894-100g 100 µg
EUR 362.5

Granzyme B (GZMB) Antibody (FITC)

abx106894-20g 20 µg
EUR 162.5

Granzyme B (GZMB) Antibody (FITC)

abx106894-50g 50 µg
EUR 250

Anti-Granzyme B/Gzmb Antibody

A00353-1 100ug/vial
EUR 352.8